Inato blog

Interview: Building Trust With Hispanic Community Patients for Clinical Research

Inato Senior DE&I Growth Manager, Atira Goodwin sits down with Greater Gift Director of Community Outreach, Perla Nunes, for a deep dive on how we can better engage hispanic community patients for research.

How Community Research Sites Are Gaining Power to Improve Patient Access to Oncology Trials

Community-based sites’ untapped patient populations, strong community bonds, and personal patient-physician relationships are the keys to unlocking the potential of oncology research.

Three Fundamental Challenges Contributing to Prolonged Industry-sponsored Clinical Trial Budget Negotiations

With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency and clarity is essential.

A Closer Look At DPHARM 2022

To a crowded room of pharma leaders, Inato’s Liz Beatty and Otsuka’s Candace Saldarini presented their teams’ findings on how collaborating with community-based research sites enabled accelerated, inclusive clinical trials.

The Most Simple Way to Diversify Clinical Trials Begins in The Heart of The Community

Today’s clinical trials struggle to include diverse patient populations due to limited, centralized trial sites that are not easily accessible for many. However, community-based research sites bring a host of diversity benefits to the clinical research ecosystem.

7 Reasons Why Community-Based Sites are Key to The Future of Research

Community sites bring powerful access to more patients and more diverse populations. They have many unique advantages that make them key to the future of research. We believe in the power of community sites for these 7 reasons:

1 2 3 4 5